Mental health and illness, Planning

Applied filters

Care Setting (7)
- Community Health Services (2)
- Health and Justice (2)
- Primary Care and PCNs (2)
- Transfer of care (5)
- Trusts (7)
Events (1)
- Past Events (1)
Guidance (82)
- Homecare (5)
- Medicines Safety (1)
- Patient Group Directions (2)
- Safety in Breastfeeding (61)
- Stability in dosette boxes (67)
- Stability outside the fridge (2)
Medicine (84)
- Agomelatine (1)
- Almotriptan (1)
- Alprazolam (1)
- Amisulpride (1)
- Aprepitant (1)
- Aripiprazole (1)
- Asenapine (1)
- Atomoxetine (1)
- Buprenorphine (1)
- Buprenorphine + Naloxone (1)
- Bupropion (1)
- Cannabidiol (1)
- Carbetocin (1)
- Carbidopa + Levodopa + Entacapone (1)
- Cariprazine (1)
- Cerliponase alfa (1)
- Clonidine (1)
- Diazepam (1)
- Donepezil (1)
- Duloxetine (1)
- Eletriptan (1)
- Entacapone (1)
- Escitalopram (1)
- Esketamine (1)
- Eslicarbazepine (1)
- Fentanyl (1)
- Fluvoxamine (1)
- Frovatriptan (1)
- Galantamine (1)
- Granisetron (1)
- Guanfacine (1)
- Idebenone (1)
- Lacosamide (1)
- Levetiracetam (1)
- Lisdexamfetamine (1)
- Lofexidine (1)
- Loprazolam (1)
- Loxapine (1)
- Lurasidone (1)
- Melatonin (1)
- Memantine (1)
- Metoclopramide (1)
- Morphine (1)
- Naloxone (1)
- Naratriptan (1)
- Nicotine (1)
- Olanzapine (2)
- Ondansetron (1)
- Orlistat (1)
- Paliperidone (1)
- Paroxetine (1)
- Pioglitazone (1)
- Pitolisant (1)
- Pramipexole (1)
- Pregabalin (1)
- Quetiapine (1)
- Rasagiline (1)
- Reboxetine (1)
- Retigabine (1)
- Risperidone (1)
- Rivastigmine (1)
- Rizatriptan (1)
- Ropinirole (1)
- Rufinamide (1)
- Sertraline (1)
- Sumatriptan (1)
- Tapentadol (1)
- Tiagabine (1)
- Tolcapone (1)
- Topiramate (1)
- Tramadol (1)
- Tramadol + Paracetamol (1)
- Varenicline (1)
- Venlafaxine (1)
- Vortioxetine (1)
- Zaleplon (1)
- Zolmitriptan (1)
- Zolpidem (1)
- Zonisamide (1)
Planning (110)
- Biosimilars (3)
- New Medicines (56)
  - CCG commissioned new medicines (49)
  - NHS England commissioned new medicines (12)
  - Pre-registration new medicines (UK/EU) (5)
- Patent expiries (67)
- Patient Group Direction Planning (2)
Publications (1)
- Research and audits (1)
Specialty (110)
- Anaesthesia and pain (17)
- Cancers (1)
- Cardiovascular system disorders (1)
- Diabetes (1)
- Ear, nose and throat disorders (2)
- Endocrine system disorders (1)
- Eyes and vision (2)
- Gastrointestinal disorders (8)
- Mental health and illness (110)
- Musculo-skeletal disorders (4)
- Neurological disorders (33)
- Nutritional and metabolic disorders (2)
- Obstetrics and gynaecology (2)
- Renal and urologic disorders (1)
- Sexual health (1)

New onset depression in autoimmune patients and the relationship with their biologics

16 March 202216 March 2022. An MUS Webinar with a discussion between specialist pharmacists

Xanomeline + trospium chloride

National Homecare Medicines Committee (NHMC) Engagement with Manufacturers Advice

4 August 2020The National Pharmaceutical Supply Group (NPSG) currently advises against participation in advisory boards sponsored by Manufacturers (Marketing Authorisation Holders). This NHMC paper supports this advice…

National Homecare Medicines Committee (NHMC) Homecare Digital Strategy

4 August 2020This is the NHMC and NCHA joint digital strategy and roadmap for the next 5 years. It sets out a direction of travel for homecare…

Medicines Shortages and Patient Group Directions

16 December 2019Medicine Shortages can occur for many reasons including manufacturing and quality control problems, delays in supply chains and discontinuations. Where a medicine supplied and/or administered…

National Homecare Medicines Committee (NHMC) Homecare Risk Assessment

10 December 2019To support organisations in establishing a robust risk assessment process for new homecare medicines services the NHMC has developed a tool for local use. …

Ulotaront

Using a Patient Group Direction to supply or administer a medication which is part of a clinical trial, study or pilot

26 June 2019The below summary advises on the use of PGDs to supply or administer a medication which is part of a clinical trial, study or pilot

SPS - Specialist Pharmacy Service

NHS

Mental health and illness, Planning

110 results

New onset depression in autoimmune patients and the relationship with their biologics

BI425809

Seltorexant